Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04119869 · ClinicalTrials.gov registry record · NA

Smart Phone App Intervention In Young Adults With Cancer

A NA study, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT04119869 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04119869, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

This research study aims to explore the feasibility and acceptability of a smartphone application intervention, called iaya, among young adults with cancer.

Interventions

  • OTHER iaya

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2019-11-11
Est. Completion 2020-06-29
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT04119869

The ClinicalTrials.gov registry entry for NCT04119869 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which iaya is the first listed.

NCT04119869 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04119869 about?

NCT04119869 is a clinical study titled "Smart Phone App Intervention In Young Adults With Cancer". This research study aims to explore the feasibility and acceptability of a smartphone application intervention, called iaya, among young adults with cancer.

What is the current status of trial NCT04119869?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-11-11. Estimated completion is 2020-06-29.

What interventions are being tested in trial NCT04119869?

The interventions under investigation include: iaya (OTHER).

Who is sponsoring clinical trial NCT04119869?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.